We are delighted to feature Dr. Neeraj Agarwal as a key figure in the oncology community.
Dr. Neeraj Agarwal is a Professor of Medicine and holds the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI) at the University of Utah. He also serves as the Director of both the Genitourinary Oncology (GU) Program and the Center of Investigational Therapeutics (CIT) at HCI.
In addition to his roles at HCI, Dr. Agarwal is an esteemed Advisor to the Oncology Drug Advisory Committee of the U.S. Food and Drug Administration (FDA). He leads the early therapeutics efforts in the SWOG Genitourinary Cancers Committee and is the Chief Editor of ASCO Daily News, where he plays a vital role in disseminating the latest advancements and research in oncology.
Follow Dr. Neeraj Agarwal on X/Twitter and LinkedIn to stay updated on his contributions to genitourinary oncology, innovative cancer research, and the latest developments in the field.
About Dr. Neeraj Agarwal
Dr. Neeraj Agarwal is a prominent oncologist with a distinguished career in cancer research and treatment. As a Professor of Medicine and Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, he leads pivotal programs focused on genitourinary oncology and investigational therapeutics.
His expertise extends to his advisory role with the Oncology Drug Advisory Committee at the FDA and his leadership in the SWOG Genitourinary Cancers Committee, where he guides early therapeutic approaches. Additionally, as Chief Editor of ASCO Daily News, Dr. Agarwal provides critical insights and updates on oncology research and practice.
Stay tuned for more OncoInfluencers and explore previous profiles on our website to discover other influential voices in the oncology community.
